Concepedia

Publication | Open Access

A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study

DOIFull Paper Access

50

Citations

27

References

2012

Year

Torsak Bunupuradah, Ploenchan Chetchotisakd, Jintanat Ananworanich, Warangkana Munsakul, Supunnee Jirajariyavej, Pacharee Kantipong, Wisit Prasithsirikul, Somnuek Sungkanuparph, Chureeratana Bowonwatanuwong, Virat Klinbuayaem,
Antiviral Therapy

Abstract

In PI-naive patients failing NNRTI-based first-line HAART, mono-LPV/r had a significantly lower proportion of patients with HIV RNA<50 copies/ml compared to the TDF/3TC/LPV/r treatment. Thus, mono-LPV/r should not be recommended as a second-line option.

References

YearCitations

Page 1